Clinical Trial Update: Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing ticagrelor and clopidogrel during reperfusion in patients with acute myocardial infarction, including those with No-Reflow Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• No-reflow Phenomenon

Drugs mentioned

• BRILINTA (ticagrelor)
• Plavix (clopidogrel)

Snippet

Sponsor: First Hospital of China Medical University | Conditions: Myocardial Infarction, No-Reflow Phenomenon | Phase 4 | Status: UNKNOWN